Notice
Recent Posts
Recent Comments
| 일 | 월 | 화 | 수 | 목 | 금 | 토 |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 |
Tags
- China
- cgi korea
- Investment
- PEF
- LOTTE
- LOI
- OTCBB
- Letter of intent
- M&A
- sk
- taiwan
- Confidential Agreement
- hong kong
- CA
- Japan Tobacco
- nda
- case study
- Korea M&A
- acquisition
- Bank
- Korea
- Merger
- China Construction Bank
- Japan
- capital gate
- buyout
- private equity
- Malaysia
- Acquistion
- securities
Archives
- Today
- Total
Korea M&A Corporation
GlaxoSmithKline and OncoMed Pharmaceuticals form strategic alliance
GlaxoSmithKline (GSK) and OncoMed Pharmaceuticals (OncoMed) today announced a worldwide strategic alliance to discover, develop and market novel antibody therapeutics to target cancer stem cells which are believed to play a key role in the establishment, metastasis and recurrence of cancer. The alliance with GSK will be conducted through its Center of Excellencefor External Drug Discovery (CEEDD..
News/ETC
2007. 12. 15. 09:13